Senseonics to release Q1 2026 earnings and hold conference call on May 7, 2026

Senseonics Holdings, Inc., a medical technology company specializing in implantable continuous glucose monitoring systems, will announce its first quarter 2026 financial results after market close on May 7, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time the same day to discuss its performance. Investors can access the webcast via Senseonics' website. This update follows the company's recent $80 million public offering of common stock and pre-funded warrants, signaling ongoing growth and investor interest.